Structural variation drives enhancer hijacking via 3D genome disruption in ccRCC - Takeaways - MDSpire

Structural variation drives enhancer hijacking via 3D genome disruption in ccRCC

  • By

  • Yu Dong

  • Wenjiao Xia

  • Zitong Yang

  • Liangliang Ren

  • Hongru Wang

  • Yiyang Zhou

  • Qinchen Li

  • Zhi Chen

  • Zhinan Xia

  • Yichun Zheng

  • Feifan Wang

  • Ning He

  • Bing Cheng

  • Dongmei Ma

  • Wei Shao

  • Wei Guo

  • Shuwen Wang

  • Ziqiao Liu

  • Junxiao Shen

  • Yiming Qi

  • Xuke Gong

  • Juan Jin

  • Bo Xie

  • Guixin Zhu

  • Cheng Zhang

  • January 6, 2026

  • 0 min

Share

  • 1

    Clear cell renal cell carcinoma (ccRCC) accounts for 70-80% of renal cell carcinoma cases and is characterized by high heterogeneity and aggressiveness.

  • 2

    Structural variants (SVs) significantly contribute to the genetic variation in ccRCC and can disrupt gene expression and regulatory networks.

  • 3

    Advancements in long-read sequencing technologies enable precise detection of SVs and their impact on 3D genome architecture in ccRCC.

  • 4

    The study identifies a novel enhancer hijacking event that activates the proto-oncogene SEMA5B, revealing new therapeutic targets.

  • 5

    A machine learning-based prognostic model developed from enhancer hijacking events shows robust predictive performance for ccRCC outcomes.

Original Source(s)

Structural variation drives enhancer hijacking via 3D genome disruption in ccRCC

  • by Yu Dong, Wenjiao Xia, Zitong Yang, Liangliang Ren, Hongru Wang, Yiyang Zhou, Qinchen Li, Zhi Chen, Zhinan Xia, Yichun Zheng, Feifan Wang, Ning He, Bing Cheng, Dongmei Ma, Wei Shao, Wei Guo, Shuwen Wang, Ziqiao Liu, Junxiao Shen, Yiming Qi, Xuke Gong, Juan Jin, Bo Xie, Guixin Zhu, Cheng Zhang

  • January 6, 2026

Related Content

Rethinking the evidence for intensive surveillance after renal tumor ablation

Correction: MRI-based habitat radiomics for predicting WHO/ISUP nuclear grade in clear cell renal cell carcinoma

Endogenous Competition of circ_001024 for miR-145-3p: Implications for GLUT5 Regulation in Renal Cell Carcinoma